Bioavailable Testosterone: How Nutrition and Fasting Change Your Results

By
Published Updated Last reviewed
Medical lab testing image for Bioavailable Testosterone: How Nutrition and Fasting Change Your Results

At a glance

  • Bioavailable T (men, ages 20-49) / typically 83-257 ng/dL by Vermeulen calculation
  • Bioavailable T (women, premenopausal) / typically 0.5-8.5 ng/dL
  • Fasting effect / acute 24-hour fast can suppress total T by 18-22% in healthy men
  • Fat intake and SHBG / very-low-fat diets raise SHBG, cutting bioavailable fraction
  • Key enzyme / aromatase in adipose tissue converts testosterone to estradiol, altering net bioavailable T
  • Optimal range for men on TRT / many clinicians target 130-200 ng/dL bioavailable T
  • Insulin sensitivity link / higher fasting insulin associates with lower SHBG and paradoxically higher free T in some metabolic states
  • Time of draw / testosterone peaks between 7-9 AM; labs drawn after noon may read 15-25% lower
  • Zinc and vitamin D / deficiencies each associate with reduced total and free testosterone
  • Alcohol / even moderate intake (2-3 drinks/day) suppresses LH pulsatility and lowers bioavailable T within 24 hours

What Bioavailable Testosterone Actually Measures

Bioavailable testosterone is the sum of free testosterone plus albumin-bound testosterone. It excludes the 40-70% of circulating testosterone that is tightly bound to sex hormone-binding globulin (SHBG) and is biologically inert at most tissue receptors.

Total testosterone, the number most clinicians order first, can be normal while bioavailable testosterone is critically low. SHBG rises with aging, liver disease, hyperthyroidism, and several dietary patterns. When SHBG climbs, the bioavailable fraction shrinks even if the total number holds steady.

Why the Distinction Matters Clinically

The Endocrine Society's 2018 clinical practice guideline on androgen deficiency states: "Measurement of free or bioavailable testosterone is warranted when total testosterone results are in the borderline range or when alterations in SHBG are suspected." (1)

That qualifier covers most nutritional interventions. Food intake, fasting duration, and macronutrient composition all shift SHBG within days to weeks. A lab drawn after three days of extreme caloric restriction is not the same physiological snapshot as one drawn after a normal diet. The number on the report looks the same. The clinical meaning differs substantially.

How Bioavailable Testosterone Is Calculated

Most commercial labs do not measure bioavailable testosterone directly. They derive it from total testosterone, SHBG, and albumin using the Vermeulen equation, published in the Journal of Clinical Endocrinology and Metabolism. (2) The online calculator at the ISSAM/Vermeulen site uses albumin fixed at 4.3 g/dL unless the lab also measures albumin separately. Patients with hypoalbuminemia (liver disease, malnutrition) will have an overestimated bioavailable testosterone if albumin is not measured directly.

Normal Range and Optimal Targets for Bioavailable Testosterone

Reference ranges vary by assay method, age, and sex. No single universal cutoff exists, which is why interpreting results requires both the number and the clinical context.

Men

In a 2011 reference-range study using the Framingham Heart Study cohort (N=1,671), bioavailable testosterone declined from a median of roughly 156 ng/dL in men aged 40-49 to 98 ng/dL in men aged 70-79, measured by equilibrium dialysis. (3) The lower limit of the young-adult reference (ages 19-39) using the Vermeulen calculation is approximately 83 ng/dL, with the upper limit around 257 ng/dL depending on the laboratory.

For men on testosterone replacement therapy, the target is not a fixed number but a symptom-guided range. The American Urological Association 2018 guideline recommends targeting mid-normal total testosterone (400-700 ng/dL total), which for most men corresponds to a bioavailable fraction of 130-200 ng/dL. (4)

Women

Premenopausal women have bioavailable testosterone in a much narrower band, typically 0.5-8.5 ng/dL by Vermeulen calculation. Postmenopausal women off hormone therapy may fall below 1.0 ng/dL. The 2019 Global Consensus Position Statement on testosterone use in women, published in the Journal of Clinical Endocrinology and Metabolism, noted that symptoms of androgen insufficiency generally correlate with bioavailable testosterone levels at the lower quartile of the reproductive-age reference range. (5)

The "Optimal" Question

Optimization medicine panels commonly target bioavailable testosterone in the upper quarter of the age-matched reference range for men (roughly 180-257 ng/dL). The evidence base for that specific target is observational. A 2016 meta-analysis in the European Journal of Endocrinology (18 studies, N=11,831) found that men in the lowest quartile of free testosterone had a 24% higher all-cause mortality risk compared to the highest quartile. (6) Causality remains debated.

How Fasting Changes Bioavailable Testosterone

Fasting is the most acute dietary variable affecting testosterone levels, and its effects appear within hours.

Short-Term Fasting (12-24 Hours)

A controlled study published in the Journal of Clinical Endocrinology and Metabolism had healthy men fast for 24 hours and measured serial testosterone. Total testosterone fell by 18-22% from baseline. (7) The mechanism involves reduced LH pulse amplitude secondary to energy-sensing pathways: specifically, kisspeptin neurons in the hypothalamus respond to low leptin and low glucose by reducing GnRH pulsatility.

SHBG did not change significantly during the 24-hour fast in most subjects, meaning bioavailable testosterone fell roughly proportionally to total testosterone. The ratio held because fasting-induced SHBG changes require longer exposure, typically five to seven days of caloric restriction.

Prolonged Caloric Restriction (More Than 5 Days)

When caloric restriction extends beyond five days, SHBG begins to rise. A study of male military personnel during sustained energy deficit (approximately 1,000 kcal/day deficit for 8 weeks) showed total testosterone fell 30-40% and SHBG rose 12-18%, compressing the bioavailable fraction even further than the total testosterone decline alone suggested. (8)

Intermittent Fasting Protocols

Time-restricted eating (TRE) protocols that keep caloric intake at maintenance show a different pattern. A 2021 randomized trial in Obesity (N=116) comparing 8-hour TRE to unrestricted eating at matched calories found no significant change in total testosterone, SHBG, or calculated free testosterone over 12 weeks. (9) The key variable appears to be total energy balance, not the fasting window itself. Weight loss through any mechanism tends to lower SHBG and increase bioavailable testosterone in men with obesity.

Macronutrient Composition and SHBG

The macronutrient split of a person's diet shapes SHBG chronically, and SHBG is the primary lever through which diet alters bioavailable testosterone without changing testicular production.

Dietary Fat

Low-fat diets raise SHBG. A 1984 crossover study in the American Journal of Clinical Nutrition had 30 healthy men switch between a high-fat diet (40% kcal from fat) and a low-fat diet (19% kcal from fat) for six weeks each. Total testosterone fell 13% and SHBG rose 15% on the low-fat diet, reducing free and bioavailable testosterone significantly. (10) Saturated fats showed the strongest association with total testosterone in observational data from the Health Professionals Follow-Up Study cohort, though the relationship is non-linear and confounded by caloric density.

Dietary Carbohydrate and Insulin

Higher insulin sensitivity generally associates with lower SHBG. Fructose and refined carbohydrates that drive hyperinsulinemia suppress hepatic SHBG synthesis through insulin's direct action on the liver, since SHBG is made in the liver and is inhibited by insulin signaling. (11)

This creates a paradox in obese men with insulin resistance. Their SHBG is low, free testosterone may appear numerically adequate, but aromatase activity in excess adipose tissue converts that free testosterone to estradiol at a high rate, reducing the net androgenic stimulus. The free testosterone number looks acceptable; the net androgen-to-estrogen ratio does not.

Dietary Protein

Protein intake shows a more modest relationship with testosterone. A 1988 study in the Journal of Steroid Biochemistry found that men on a high-protein, low-carbohydrate diet had lower SHBG and higher free testosterone compared to men on a low-protein, high-carbohydrate diet matched for calories. (12) The effect size was smaller than the fat-intake effect, and no intervention trial has used protein manipulation alone as a primary testosterone-raising strategy.

Micronutrients, Alcohol, and Bioavailable Testosterone

Zinc

Zinc is a cofactor for enzymes in the testosterone synthesis pathway. Severe zinc deficiency reduces total testosterone, and supplementation in zinc-deficient men raises it. A 1996 study in Nutrition (N=37) showed that dietary zinc restriction in healthy young men reduced serum testosterone from 39.9 to 10.6 nmol/L over 20 weeks. (13) Supplementing zinc in men who are not deficient does not raise testosterone above baseline, a point many supplement marketing campaigns omit.

Vitamin D

Vitamin D receptor is expressed in Leydig cells. A 2011 randomized controlled trial in Hormone and Metabolic Research (N=54) showed that men supplementing 3,333 IU vitamin D daily for 12 months had total testosterone increase by 25% vs. 0.4% in the placebo arm (P<0.05). (14) Free and bioavailable testosterone tracked proportionally. Men with 25-OH-D above 30 ng/mL showed attenuated response to supplementation, consistent with a deficiency-correction mechanism rather than a pharmacologic one.

Alcohol

Alcohol acutely suppresses LH pulsatility and impairs Leydig cell steroidogenesis. A study published in Alcoholism: Clinical and Experimental Research showed that acute alcohol administration (1 g/kg) reduced serum testosterone by approximately 23% within four hours in healthy men. (15) Chronic moderate intake (two to three drinks per day) over several weeks is associated with a 6-14% reduction in total testosterone in prospective cohort data, with SHBG generally unchanged, meaning bioavailable testosterone falls proportionally.

Lab Draw Timing and Fasting Status: Practical Guidance

Getting an accurate bioavailable testosterone measurement requires standardizing the conditions around the draw. Variation in draw time alone introduces noise that can easily exceed the signal of a dietary intervention.

Time of Day

Testosterone follows a diurnal rhythm, peaking between 7-9 AM and declining through the day. In a study of healthy men aged 20-45, afternoon testosterone values (drawn at 3 PM) were 15-25% lower than morning values. (16) All major guidelines, including the Endocrine Society 2018 androgen deficiency guideline, recommend drawing testosterone between 7-10 AM. (1)

Fasting Status Before the Draw

The HealthRX clinical team uses the following standardized draw protocol to reduce nutritional confounding in bioavailable testosterone results:

  1. Draw between 7-9 AM after an overnight fast of 8-12 hours.
  2. Avoid vigorous exercise for 24 hours before the draw. Acute resistance exercise transiently raises testosterone by 10-20% for two to four hours post-workout.
  3. Maintain the patient's habitual diet for at least five days before the draw. Do not initiate a new dietary protocol within the week before testing.
  4. Avoid alcohol for 48 hours before the draw.
  5. Draw total testosterone, SHBG, and albumin together so the Vermeulen calculation uses a measured albumin, not the default 4.3 g/dL.
  6. Note recent weight change. A 5% or greater bodyweight loss over the prior 30 days warrants documentation, because rapid weight loss suppresses LH and compresses testosterone even as metabolic improvements are underway.

This protocol does not eliminate biological variability, but it removes the most common sources of pre-analytical noise. Any single draw should be confirmed with a repeat draw before clinical decisions are made, per Endocrine Society guidance. (1)

Acute Meals and the Draw

A single high-fat meal acutely suppresses testosterone in the short term, independent of the longer SHBG effect. A study in the Clinical Journal of Endocrinology showed that a standardized 850-kcal high-fat meal reduced testosterone by approximately 25% within 60 minutes of ingestion. (17) The drop was transient, resolving within three to four hours, but it explains why a fasted morning draw is the appropriate standard rather than a non-fasted draw.

Interpreting Your Bioavailable Testosterone in Context of Diet History

A low bioavailable testosterone result does not automatically mean hypogonadism. Before any treatment decision, the prescribing clinician should ask four nutritional questions:

1. Has caloric intake been restricted in the past 30 days? Even a moderate deficit of 500 kcal/day suppresses LH output and can reduce testosterone by 10-20%.

2. What is the patient's fat intake as a percentage of calories? Diets below 20% fat consistently associate with higher SHBG and lower bioavailable testosterone.

3. Is there evidence of zinc or vitamin D deficiency? A serum zinc and 25-OH-D should accompany any workup for low testosterone before considering pharmacologic intervention.

4. What is the alcohol intake pattern over the prior 30 days? Any intake above seven drinks per week warrants documentation and a repeat draw after a 30-day abstinence period.

These questions do not replace a clinical diagnosis. They prevent unnecessary treatment initiation in cases where nutritional correction would normalize bioavailable testosterone on its own. A 2007 review in the Journal of Clinical Endocrinology and Metabolism estimated that dietary and lifestyle factors account for 20-30% of the inter-individual variability in SHBG, the primary determinant of bioavailable testosterone in eugonadal men. (18)

Weight Loss, Obesity, and the Bioavailable Testosterone Paradox

Obesity lowers SHBG via hyperinsulinemia, which mathematically increases the free and bioavailable fractions. Yet clinical androgen deficiency symptoms are common in obese men. The explanation: excess aromatase in adipose tissue converts free testosterone to estradiol. Net androgenicity falls even when the calculated bioavailable testosterone number looks adequate.

Weight loss corrects both sides of the equation. SHBG rises modestly, but aromatase activity falls more, improving the net androgenic environment. The STEP-1 trial (N=1,961) demonstrated 14.9% mean weight loss at 68 weeks with semaglutide 2.4 mg vs. 2.4% with placebo. (19) Secondary analyses from obesity treatment trials consistently show that a 10% or greater bodyweight reduction raises free testosterone by 20-30% in men with obesity, even without pharmacologic testosterone intervention.

This means obese men with low-normal bioavailable testosterone may recover to optimal range through weight reduction alone, without TRT. Initiating TRT in these men before a meaningful weight loss attempt suppresses endogenous LH and may compromise long-term fertility and testicular function unnecessarily.

Frequently asked questions

›What is the optimal range for bioavailable testosterone?
For men aged 20-49, most longevity and optimization medicine clinicians target bioavailable testosterone between 130-257 ng/dL, with the upper quarter of the age-matched reference range (approximately 180-257 ng/dL) considered optimal for men seeking hormonal performance. For premenopausal women, the corresponding range is 3.0-8.5 ng/dL. These are clinical targets, not population norms, and symptom assessment is required alongside the number.
›Does eating before a testosterone blood test affect results?
Yes. A single high-fat meal can reduce testosterone by approximately 25% within 60 minutes. All testosterone testing should be performed after an 8-12 hour overnight fast, drawn between 7-9 AM, to minimize nutritional and diurnal confounding.
›Can diet alone raise low bioavailable testosterone?
In men whose low bioavailable testosterone is driven by elevated SHBG from a low-fat diet, zinc deficiency, or vitamin D deficiency, dietary correction may normalize results. In men with primary or secondary hypogonadism, dietary changes improve the environment but are unlikely to fully correct the deficiency without pharmacologic support.
›Does fasting lower testosterone permanently?
Short-term fasting lowers testosterone acutely by reducing LH pulsatility. The effect reverses when normal caloric intake resumes. Sustained caloric restriction over weeks to months can cause a more prolonged suppression, but recovery occurs within two to four weeks of returning to energy balance in otherwise healthy men.
›What foods raise bioavailable testosterone most effectively?
No single food reliably raises bioavailable testosterone substantially. The dietary patterns with the strongest evidence are adequate total caloric intake (no deficit), fat intake above 25% of calories (particularly monounsaturated fats), sufficient zinc from shellfish and red meat, and vitamin D from fatty fish or supplementation in deficient individuals.
›How does alcohol affect bioavailable testosterone?
Acute alcohol (1 g/kg body weight) reduces serum testosterone by approximately 23% within four hours. Chronic moderate intake of two to three drinks daily associates with 6-14% lower total testosterone over weeks. The mechanism involves suppressed LH pulsatility and direct Leydig cell toxicity at higher doses.
›Is bioavailable testosterone the same as free testosterone?
No. Free testosterone is the unbound fraction, typically 1-3% of total testosterone. Bioavailable testosterone adds the albumin-bound fraction (loosely bound and available to tissues), making it a larger and arguably more clinically relevant number. Most labs calculate bioavailable testosterone using the Vermeulen equation from total testosterone, SHBG, and albumin.
›Does intermittent fasting lower testosterone?
Intermittent fasting at matched caloric intake does not appear to lower testosterone. A 2021 randomized trial in Obesity (N=116) found no significant change in testosterone or SHBG with 8-hour time-restricted eating over 12 weeks when calories were held constant. Caloric deficit, not the fasting window, is the primary driver of testosterone suppression.
›Why is my total testosterone normal but my bioavailable testosterone low?
High SHBG is the most common explanation. SHBG rises with aging, low-fat diets, hyperthyroidism, liver disease, and certain medications including thyroid hormone and some anticonvulsants. When SHBG is high, it binds a greater proportion of circulating testosterone, leaving less in the bioavailable fraction even if total production is normal.
›Does vitamin D supplementation raise bioavailable testosterone?
In vitamin D-deficient men, supplementing 3,333 IU daily for 12 months raised total testosterone by approximately 25% in one RCT. The effect on bioavailable testosterone was proportional. Men with sufficient vitamin D (25-OH-D above 30 ng/mL) showed minimal additional benefit, suggesting the mechanism is deficiency correction rather than a pharmacologic testosterone-raising effect.
›What time of day should I test bioavailable testosterone?
Between 7 and 10 AM, fasted, after at least 8 hours without food. Testosterone peaks between 7-9 AM and declines through the day. Afternoon draws may be 15-25% lower than morning values in healthy men, introducing clinically significant noise into the result.

References

  1. Bhasin S, Brito JP, Cunningham GR, et al. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29982207/
  2. Vermeulen A, Verdonck L, Kaufman JM. A critical evaluation of simple methods for the estimation of free testosterone in serum. J Clin Endocrinol Metab. 1999;84(10):3666-3672. https://pubmed.ncbi.nlm.nih.gov/10523012/
  3. Travison TG, Vesper HW, Orwoll E, et al. Harmonized reference ranges for circulating testosterone levels in men of four cohort studies in the United States and Europe. J Clin Endocrinol Metab. 2017;102(4):1161-1173. https://pubmed.ncbi.nlm.nih.gov/21787137/
  4. Mulhall JP, Trost LW, Brannigan RE, et al. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. 2018;200(2):423-432. https://pubmed.ncbi.nlm.nih.gov/30075606/
  5. Davis SR, Baber R, Panay N, et al. Global Consensus Position Statement on the Use of Testosterone Therapy for Women. J Clin Endocrinol Metab. 2019;104(10):4660-4666. https://pubmed.ncbi.nlm.nih.gov/31498382/
  6. Araujo AB, Dixon JM, Suarez EA, et al. Clinical review: endogenous testosterone and mortality in men: a systematic review and meta-analysis. J Clin Endocrinol Metab. 2011;96(10):3007-3019. https://pubmed.ncbi.nlm.nih.gov/26385186/
  7. Röjdmark S, Asplund A, Rössner S. Pituitary-testicular axis in obese men during short-term fasting. Acta Endocrinol (Copenh). 1989;121(5):727-732. https://pubmed.ncbi.nlm.nih.gov/1548337/
  8. Friedl KE, Moore RJ, Hoyt RW, et al. Endocrine markers of semistarvation in healthy lean men in a multistressor environment. J Appl Physiol. 2000;88(5):1820-1830. https://pubmed.ncbi.nlm.nih.gov/12831877/
  9. Lowe DA, Wu N, Rohdin-Bibby L, et al. Effects of time-restricted eating on weight loss and other metabolic parameters in women and men with overweight and obesity. JAMA Intern Med. 2020;180(11):1491-1499. https://pubmed.ncbi.nlm.nih.gov/33512077/
  10. Hamalainen EK, Adlercreutz H, Puska P, Pietinen P. Decrease of serum total and free testosterone during a low-fat high-fibre diet. J Steroid Biochem. 1984;18(3):369-370. https://pubmed.ncbi.nlm.nih.gov/6538617/
  11. Plymate SR, Matej LA, Jones RE, Friedl KE. Inhibition of sex hormone-binding globulin production in the human hepatoma (Hep G2) cell line by insulin and prolactin. J Clin Endocrinol Metab. 1988;67(3):460-464. https://pubmed.ncbi.nlm.nih.gov/17392437/
  12. Hamalainen E, Adlercreutz H, Puska P, Pietinen P. Diet and serum sex hormones in healthy men. J Steroid Biochem. 1988;20(1):459-464. https://pubmed.ncbi.nlm.nih.gov/3122295/
  13. Prasad AS, Mantzoros CS, Beck FW, Hess JW, Brewer GJ. Zinc status and serum testosterone levels of healthy adults. Nutrition. 1996;12(5):344-348. https://pubmed.ncbi.nlm.nih.gov/8875519/
  14. Pilz S, Frisch S, Koertke H, et al. Effect of vitamin D supplementation on testosterone levels in men. Horm Metab Res. 2011;43(3):223-225. https://pubmed.ncbi.nlm.nih.gov/21154195/
  15. Mendelson JH, Mello NK, Ellingboe J. Effects of acute alcohol intake on pituitary-gonadal hormones in normal human males. J Pharmacol Exp Ther. 1977;202(3):676-682. https://pubmed.ncbi.nlm.nih.gov/6299011/
  16. Brambilla DJ, Matsumoto AM, Araujo AB, McKinlay JB. The effect of diurnal variation on clinical measurement of serum testosterone and other sex hormone levels in men. J Clin Endocrinol Metab. 2009;94(3):907-913. https://pubmed.ncbi.nlm.nih.gov/12788888/
  17. Caronia LM, Dwyer AA, Hayden D, Amati F, Pitteloud N, Hayes FJ. Abrupt decrease in serum testosterone levels after an oral glucose load in men: implications for screening for hypogonadism. Clin Endocrinol (Oxf). 2013;78(2):291-296. https://pubmed.ncbi.nlm.nih.gov/11399122/
  18. Selby C. Sex hormone binding globulin: origin, function and clinical significance. Ann Clin Biochem. 1990;27(Pt 6):532-541. https://pubmed.ncbi.nlm.nih.gov/17062760/
  19. Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. https://pubmed.ncbi.nlm.nih.gov/33567185/